COLORADO THERAPEUTICS

colorado-therapeutics-logo

Colorado Therapeutics, LLC, (“Company”) a privately held company, is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications. The Company is leveraging over 15 years of innovative and proprietary tissue processing technology to produce a superior biologic product that combines the benefits of currently available biologic and synthetic products.

#People #Website #More

COLORADO THERAPEUTICS

Industry:
Biotechnology Health Care Manufacturing Medical Device

Founded:
2015-01-01

Address:
Louisville, Colorado, United States

Country:
United States

Website Url:
http://www.co-therapeutics.com

Total Employee:
11+

Status:
Active

Contact:
(303)469-9459

Email Addresses:
info@CO-Therapeutics.com

Total Funding:
6.87 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box


Current Employees Featured

not_available_image

Eric Schaber
Eric Schaber Vice President @ Colorado Therapeutics
Vice President

not_available_image

Joseph Horn
Joseph Horn President and CEO @ Colorado Therapeutics
President and CEO

valerie-k-ray_image

Valerie K. Ray
Valerie K. Ray Chief Operating Officer @ Colorado Therapeutics
Chief Operating Officer
2017-06-12

Founder


not_available_image

Joseph Horn

Official Site Inspections

http://www.co-therapeutics.com

  • Host name: 192.252.150.204
  • IP address: 192.252.150.204
  • Location: Waltham United States
  • Latitude: 42.3972
  • Longitude: -71.2434
  • Metro Code: 506
  • Timezone: America/New_York
  • Postal: 02451

Loading ...

More informations about "Colorado Therapeutics"

CO Therapeutics® - Bringing New Perspective to Soft Tissue Repair

CO Therapeutics® brings new perspectives to developing innovative products for soft tissue repair, reinforcement, and regenerative applications. ... BROOMFIELD, Colo. – October 28, …See details»

Colorado Therapeutics - Crunchbase Company Profile & Funding

Contact Email info@CO-Therapeutics.com Phone Number (303)469-9459 Colorado Therapeutics, LLC, (“Company”) a privately held company, is focused on developing …See details»

Colorado Therapeutics LLC - LinkedIn

Colorado Therapeutics LLC | 373 followers on LinkedIn. An advancement in crosslinking technology for soft tissue repair | Colorado Therapeutics is focused on developing xenogenic …See details»

Leadership Archives - CO Therapeutics®

Colorado Therapeutics Submits 510(k) for a Novel Xenograft Implant for Soft Tissue Repairs; Colorado Therapeutics Created and Launches New Website; Recent Comments. Archives. …See details»

Therapeutics Initiative | Organization - University of British Columbia

The Steering Committee (SC) of the Therapeutics Initiative (TI) supports the day-to-day decisions of the Co-Managing Directors by providing advice on a variety of important issues such as …See details»

Thomas P. Reagan - co-therapeutics.com

Thomas Reagan joined Colorado Therapeutics LLC as a Board of Director in 2015 and is an ongoing active corporate and financial advisor. Mr. Reagan is also a Board of Director of …See details»

Colorado Therapeutics, LLC - CMOCRO

Colorado Therapeutics, LLC, (“Company”) a privately held company, is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a …See details»

CoA Therapeutics - Crunchbase Company Profile

Organization. CoA Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. CoA Therapeutics develops novel therapies for difficult to treat and rare genetic disorders. ...See details»

Co-D Therapeutics - Crunchbase Company Profile

Co-D Therapeutics, Inc. is a preclinical stage biopharmaceutical company based in Madison, Wisconsin. Co-D is an innovative drug development company dedicated to developing first-in-class combination nano-medicines with high …See details»

Colorado's Top 23 Biopharmaceutical Companies - Inven

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on creating novel precision medicines for the treatment of rare muscle disorders. 9. OnKure Therapeutics ... CARE Research is a preclinical contract research …See details»

Dr Nathan Bryan: Innovator in Nitric Oxide Solutions

Nov 14, 2024 Dr Nathan Bryan was the first to describe nitrite and nitrate as indispensable nutrients required for optimal cardiovascular health.He was the first to demonstrate and …See details»

CoA Therapeutics - Org Chart, Teams, Culture & Jobs - The Org

CoA Therapeutics was founded in 2018 with the aim of harnessing advances in understanding of the CoA pathway to develop novel therapies for difficult to treat and rare genetic disorders. …See details»

Co-D Therapeutics, Inc. (Co-D Therapeutics, Inc.) - 药物管线_专利_ …

Jan 23, 2025 了解Co-D Therapeutics, Inc. (Co-D Therapeutics, Inc.)公司的药物管线,治疗领域,技术平台,以及它的,疾病领域:肿瘤,技术平台:小分子化药,药物:Triolimus。See details»

about_hero - CO Therapeutics®

©2024 Colorado Therapeutics LLC.. About Us; Technology; XI-S+® Events & News; Contact Us; CareersSee details»

Merck to Acquire US Biopharma Company SpringWorks …

Apr 28, 2025 Merck and biopharmaceutical company SpringWorks Therapeutics, have entered into a definitive agreement for Merck to acquire SpringWorks. ... an investigational therapy …See details»

CoA Therapeutics - VentureRadar

" CoA Therapeutics was founded in 2018 with the aim of developing novel therapies for difficult to treat and rare genetic disorders by harnessing advances in understanding of the CoA …See details»

Home | CoA Therapeutics

CoA Therapeutics is targeting Coenzyme-A for patients with PKAN, organic acidurias and other diseases of CoA sequestration. About CoA and its Biosynthetic Pathway. Coenzyme A (CoA) …See details»

CoHead Therapeutics

At COHEAD Therapeutics, we have developed a unique innovative platform (CovAI) to identify reactive non-cysteine residues including lysines and optimize potent, selective covalent …See details»

Axsome Therapeutics at Citizens JMP Life Sciences: Strategic …

35 minutes ago On Wednesday, 07 May 2025, Axsome Therapeutics (NASDAQ:AXSM) presented at The Citizens JMP Life Sciences Conference 2025, showcasing a robust first quarter.See details»

Technology - CO Therapeutics®

1 Colorado Therapeutics LLC. Data on file. 2 Corey Deeken et. al., Differentiation of Biologic Scaffold Materials Through Physicomechanical, Thermal, and Enzymatic Degradation …See details»